+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Hepatocyte growth factor plays a critical role in the regulation of cytokine production and induction of endothelial progenitor cell mobilization: a pilot gene therapy study in patients with coronary heart disease



Hepatocyte growth factor plays a critical role in the regulation of cytokine production and induction of endothelial progenitor cell mobilization: a pilot gene therapy study in patients with coronary heart disease



Clinical and Experimental Pharmacology and Physiology 36(8): 790-796



1. There is growing evidence of the beneficial effects of hepatocyte growth factor (HGF) in myocardial infarction, heart failure and occlusive peripheral arterial disease. The aim of the present study was to evaluate the effects of intracoronary administration of an adenovirus vector encoding the human HGF gene (Ad-HGF) on serum levels of cytokines and mobilization of CD34(+) and CD117(+) cells in patients with coronary heart disease. 2. Twenty-one patients with severe coronary artery disease were recruited to the study: 11 patients received both a stent and administration of Ad-HGF; the remaining 10 patients received a stent alone and served as the control group. Blood samples were obtained from the femoral vein before and then 6 and 24 h, 3 and 6 days and 2 weeks after treatment for the isolation of serum and peripheral blood mononuclear cells. Intracoronary administration of Ad-HGF in patients with coronary heart disease resulted in high levels of HGF gene expression, as well as its receptor c-met, compared with the control group, as demonstrated by real-time reverse transcription-polymerase chain reaction. In addition, serum levels of HGF, vascular endothelial growth factor, monocyte chemoattractant protein-1 and interleukin (IL)-10 were increased and serum levels of IL-8 were decreased in patients administered Ad-HGF compared with the control group. The percentage of CD34(+) and CD117(+) cells in the peripheral blood increased in patients administered Ad-HGF. 3. In conclusion, HGF gene therapy may play an important role in the regulation of cytokines and the induction of endothelial progenitor cell mobilization in patients with coronary heart disease.

Please choose payment method:






(PDF emailed within 0-6 h: $19.90)

Accession: 053519816

Download citation: RISBibTeXText

PMID: 19215239

DOI: 10.1111/j.1440-1681.2009.05151.x


Related references

Is there a relationship between exercise-induced endothelial progenitor cell mobilization and cytokine concentrations in patients with premature coronary heart disease [corrected. Polskie Archiwum Medycyny Wewnetrznej 125(4): 305-307, 2015

Effect of intracoronary adenovirus vector encoding hepatocyte growth factor gene on hematopoietic stem cells mobilization in patients with extensive coronary heart disease. Zhonghua Xin Xue Guan Bing Za Zhi 35(6): 504-508, 2007

Study of Cytokine Profile of Cultured "Early" and "Late" Endothelial Progenitor Cells in Peripheral Blood of Chronic Heart Failure Patients after Mobilization Course with Granulocyte Colony-Stimulating Factor. Bulletin of Experimental Biology and Medicine 160(2): 249-251, 2015

Mobilization of haematopoietic and non-haematopoietic cells by granulocyte-colony stimulating factor and vascular endothelial growth factor gene therapy in patients with stable severe coronary artery disease. Scandinavian Cardiovascular Journal 41(6): 397-404, 2007

Safety of vascular endothelial and hepatocyte growth factor gene therapy in patients with critical limb ischemia. Current Neurovascular Research 8(3): 183-189, 2011

Role of circulating vascular endothelial growth factor and hepatocyte growth factor in patients with coronary artery disease. Heart and Vessels 15(3): 105-111, 2000

Role of circulating vascular endothelial growth factor and hepatocyte growth factor in patients with coronary artery disease. Heart & Vessels 15(3): 105-111, 2000

An essential role of vascular endothelial growth factor in the mechanism by which endothelial progenitor cell therapy can reduce myocardial infarct size after coronary artery ligation. Circulation 104(17 Suppl.): II 229, 2001

Hepatocyte nuclear factor 1alpha plays a critical role in PCSK9 gene transcription and regulation by the natural hypocholesterolemic compound berberine. Journal of Biological Chemistry 284(42): 28885-28895, 2009

Caveolin plays a central role in endothelial progenitor cell mobilization and homing in SDF-1-driven postischemic vasculogenesis. Circulation Research 98(9): 1219-1227, 2006

Tea polyphenols decrease serum levels of prostate-specific antigen, hepatocyte growth factor, and vascular endothelial growth factor in prostate cancer patients and inhibit production of hepatocyte growth factor and vascular endothelial growth factor in vitro. Cancer Prevention Research 2(7): 673-682, 2009

Endothelial injury induced by coronary angioplasty triggers mobilization of endothelial progenitor cells in patients with stable coronary artery disease. Journal of Thrombosis and Haemostasis 4(5): 979-981, 2006

Hepatocyte growth factor, but not vascular endothelial growth factor, attenuates angiotensin II-induced endothelial progenitor cell senescence. Hypertension 53(1): 77-82, 2009

Essential role of bone marrow fibroblast growth factor-2 in the effect of estradiol on reendothelialization and endothelial progenitor cell mobilization. American Journal of Pathology 169(5): 1855-1862, 2006

Akt-centered amplification loop plays a critical role in vascular endothelial growth factor/stromal cell-derived factor 1-α cross-talk and cardioprotection. Chinese Medical Journal 124(22): 3800-3805, 2011